179 related articles for article (PubMed ID: 30297265)
1. Association Between Primary Payer Status and Survival in Patients With Stage III Colon Cancer: An National Cancer Database Analysis.
Ahmed A; Tahseen A; England E; Wolfe K; Simhachalam M; Homan T; Sitenga J; Walters RW; Silberstein PT
Clin Colorectal Cancer; 2019 Mar; 18(1):e1-e7. PubMed ID: 30297265
[TBL] [Abstract][Full Text] [Related]
2. Impact of payer status on survival in parotid malignancy.
Stubbs VC; Rajasekaran K; Chen J; Cannady SB; Brant JA; Newman JG
Am J Otolaryngol; 2019; 40(4):555-559. PubMed ID: 31097206
[TBL] [Abstract][Full Text] [Related]
3. Association of health insurance status with presentation, treatment and outcomes in soft tissue sarcoma.
Jain V; Venigalla S; Sebro RA; Karakousis GC; Wilson RJ; Weber KL; Shabason JE
Cancer Med; 2019 Oct; 8(14):6295-6304. PubMed ID: 31483578
[TBL] [Abstract][Full Text] [Related]
4. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis.
Halpern MT; Ward EM; Pavluck AL; Schrag NM; Bian J; Chen AY
Lancet Oncol; 2008 Mar; 9(3):222-31. PubMed ID: 18282806
[TBL] [Abstract][Full Text] [Related]
5. Association of Insurance and Community-Level Socioeconomic Status With Treatment and Outcome of Squamous Cell Carcinoma of the Pharynx.
Shin JY; Yoon JK; Shin AK; Blumenfeld P; Mai M; Diaz AZ
JAMA Otolaryngol Head Neck Surg; 2017 Sep; 143(9):899-907. PubMed ID: 28662244
[TBL] [Abstract][Full Text] [Related]
6. Disparities in Colon Cancer Survival by Insurance Type: A Population-Based Analysis.
Pulte D; Jansen L; Brenner H
Dis Colon Rectum; 2018 May; 61(5):538-546. PubMed ID: 29624548
[TBL] [Abstract][Full Text] [Related]
7. The influence of insurance status on treatment and outcomes in oral cavity cancer: an analysis on 46,373 patients.
Shin JY; Yoon JK; Shin AK; Diaz AZ
Int J Oral Maxillofac Surg; 2018 Oct; 47(10):1250-1257. PubMed ID: 29655817
[TBL] [Abstract][Full Text] [Related]
8. Effects of payer status on breast cancer survival: a retrospective study.
Shi R; Taylor H; McLarty J; Liu L; Mills G; Burton G
BMC Cancer; 2015 Apr; 15():211. PubMed ID: 25884399
[TBL] [Abstract][Full Text] [Related]
9. Insurance status and disparities in disease presentation, treatment, and outcomes for men with germ cell tumors.
Markt SC; Lago-Hernandez CA; Miller RE; Mahal BA; Bernard B; Albiges L; Frazier LA; Beard CJ; Wright AA; Sweeney CJ
Cancer; 2016 Oct; 122(20):3127-3135. PubMed ID: 27500561
[TBL] [Abstract][Full Text] [Related]
10. Impact of Insurance Status on Stage, Treatment, and Survival in Patients with Colorectal Cancer: A Population-Based Analysis.
Sun W; Cheng M; Zhuang S; Qiu Z
Med Sci Monit; 2019 Apr; 25():2397-2418. PubMed ID: 30939127
[TBL] [Abstract][Full Text] [Related]
11. Insurance Status and Other Non-biological Factors Predict Outcomes in Acute Myelogenous Leukemia: Analysis of Data from the National Cancer Database.
Master S; Munker R; Shi Z; Mills G; Shi R
Anticancer Res; 2016 Sep; 36(9):4915-21. PubMed ID: 27630349
[TBL] [Abstract][Full Text] [Related]
12. The effect of marital and insurance status on the survival of elderly patients with stage M1b colon cancer: a SEER-based study.
Zhou C; Zhang Y; Hu X; Fang M; Xiao S
BMC Cancer; 2021 Aug; 21(1):891. PubMed ID: 34353300
[TBL] [Abstract][Full Text] [Related]
13. Insurance Status is an Independent Predictor of Overall Survival in Patients With Stage III Non-small-cell Lung Cancer Treated With Curative Intent.
Rice SR; Vyfhuis MAL; Scilla KA; Burrows WM; Bhooshan N; Suntharalingam M; Edelman MJ; Feliciano J; Badiyan SN; Simone CB; Bentzen SM; Feigenberg SJ; Mohindra P
Clin Lung Cancer; 2020 May; 21(3):e130-e141. PubMed ID: 31708388
[TBL] [Abstract][Full Text] [Related]
14. Receipt of chemotherapy among medicare patients with cancer by type of supplemental insurance.
Warren JL; Butler EN; Stevens J; Lathan CS; Noone AM; Ward KC; Harlan LC
J Clin Oncol; 2015 Feb; 33(4):312-8. PubMed ID: 25534387
[TBL] [Abstract][Full Text] [Related]
15. Insurance correlates with improved access to care and outcome among glioblastoma patients.
Brown DA; Himes BT; Kerezoudis P; Chilinda-Salter YM; Grewal SS; Spear JA; Bydon M; Burns TC; Parney IF
Neuro Oncol; 2018 Sep; 20(10):1374-1382. PubMed ID: 29893906
[TBL] [Abstract][Full Text] [Related]
16. Multiplicative disadvantage of being an unmarried and inadequately insured woman living in poverty with colon cancer: historical cohort exploration in California.
Levitz NR; Haji-Jama S; Munro T; Gorey KM; Luginaah IN; Bartfay E; Zou G; Wright FC; Kanjeekal SM; Hamm C; Balagurusamy MK; Holowaty EJ
BMC Womens Health; 2015; 15():8. PubMed ID: 25783640
[TBL] [Abstract][Full Text] [Related]
17. An official American Thoracic Society systematic review: insurance status and disparities in lung cancer practices and outcomes.
Slatore CG; Au DH; Gould MK;
Am J Respir Crit Care Med; 2010 Nov; 182(9):1195-205. PubMed ID: 21041563
[TBL] [Abstract][Full Text] [Related]
18. Association between insurance status at diagnosis and overall survival in chronic myeloid leukemia: A population-based study.
Perry AM; Brunner AM; Zou T; McGregor KL; Amrein PC; Hobbs GS; Ballen KK; Neuberg DS; Fathi AT
Cancer; 2017 Jul; 123(13):2561-2569. PubMed ID: 28464280
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Payer Status on Survival of Patients with Stage I/II Non-small Cell Lung Cancer: NCDB 1998-2011.
Shi R; Diaz R; Shi Z; Duvall E; Mills G
Anticancer Res; 2016 Jan; 36(1):319-26. PubMed ID: 26722060
[TBL] [Abstract][Full Text] [Related]
20. Influence of insurance status and income in anaplastic astrocytoma: an analysis of 4325 patients.
Shin JY; Yoon JK; Diaz AZ
J Neurooncol; 2017 Mar; 132(1):89-98. PubMed ID: 27864706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
